Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):392–398. doi: 10.1097/QAI.0000000000002149

Table 1.

Raltegravir pharmacokinetic parameters from non-compartmental analysis [geometric mean (range)] for Cohort 1 initial doses

Dose Age at initial dose (hrs) Cmax (mg/L) AUC12 (mg*hr/L) T ½ (hrs) Tmax (hrs) C24h (mg/L) V2/F (L/kg) Cl/F (L/kg/hr)
3 mg/kg n=6 17.2 (9.9–25.4) 3.36 (2.00–5.32 mg/L) 29.5 (17.4–44.0 mg*h 11.8 (7.9–15.7) 6.5 (4.1–24.0) 1.44 (0.662–3.65 mg/L) 0.56 (0.35–0.80) 0.033 (0.021–0.053)